However, our data demonstrate the suitability of pp65-IGRA for the quantification of HCMV-specific CD4+ T-cell responses and its potentiality in identifying patients at risk for, or protected from, HCMV infection after transplantation. The gene discussed is CD4; the disease is cytomegalovirus infection.